# Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

Source: https://onco.cc/trials/nct05588388/  
OnCo record `nct05588388` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of bevacizumab in lung cancer, run by Kamya Sankar, now recruiting.

## Summary

Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases is a phase 2, interventional study registered as NCT05588388 by Kamya Sankar, with a registry enrolment figure of 39 participants, started 2024-08-11 and due to reach its primary completion in 2026-12-28. Interventions recorded: Bevacizumab. Conditions listed: Extensive-stage Small-cell Lung Cancer; Liver Metastases. Primary outcome: 6- month Progression Free Survival (PFS) rate. Lung eligibility wording from the registry: "* Histologically or cytologically confirmed ES-SCLC (per the Veterans Administration Lung Study Group staging system), and radiographic confirmation of LM at diagnosis". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Also known as: BELIEVE
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT05588388
- Phase: 2
- Setting: IIT2022-05-Sankar-BELIEVE: Phase II Study of Bevacizumab in Combination With Chemoimmunotherapy and Maintenance Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
- Sponsor: Kamya Sankar
- Enrolled: 39

## Sources

- ClinicalTrials.gov NCT05588388: https://clinicaltrials.gov/study/NCT05588388

## Connected records

- cancers: [Extensive-stage small-cell lung cancer](https://onco.cc/cancers/extensive-stage-sclc/)
- technologies: [Anti-angiogenic therapy](https://onco.cc/technologies/antiangiogenic/), [Monoclonal antibodies](https://onco.cc/technologies/monoclonal-antibody/)
- drugs: [Bevacizumab](https://onco.cc/drugs/bevacizumab/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct05588388.json